No Data
No Data
Ventyx Biosciences (VTYX) Receives a Buy From LifeSci Capital
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (NASDAQ:VTYX) ("Ventyx"), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of
Express News | Ventyx Biosciences Shares Are Trading Higher. The Company Appointed Matthew Moore as COO
Ventyx Biosciences Gets New Operations Chief
Express News | Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer
Press Release: Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer
Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX), ("Ventyx"), a clinical-stage
No Data